Work

Abstract CT111: Phase 0 intratumoral microdevice study of FX-909 in bladder cancer demonstrates on-target anti-tumor activity and immune modulation, enhanced in combination with anti-PD-1

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct111

Authors: Phuong A. Nguyen, Peter M. Szabo, Joseph Kotler, Simon Chow, Bijal Kakrecha, Nnamdi Onochie, Fanni Santa, Michaela Bowden, Oliver Jonas, Matthew Mossanen, Evisa Gjini

Institutions: Mass General Brigham, Dana-Farber Cancer Institute

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154701465

Cites:

Cited by:

Related to: